🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/09/2019 86,18 86,98 83,62 86,64 +1,10% 3,90% 1.714.300
06/09/2019 88,98 88,98 85,23 85,70 -3,73% 4,21% 1.363.200
05/09/2019 86,45 89,83 85,88 89,02 +3,36% 4,57% 1.752.200
04/09/2019 87,64 88,72 85,70 86,13 -0,73% 3,45% 1.542.200
03/09/2019 89,65 90,55 86,48 86,76 -3,76% 4,54% 1.464.500
30/08/2019 90,27 91,49 89,20 90,15 -0,76% 2,54% 1.152.900
29/08/2019 92,53 93,74 89,75 90,84 -0,96% 4,31% 1.382.900
28/08/2019 91,87 93,96 90,88 91,72 -0,47% 3,35% 1.286.500
27/08/2019 94,16 95,50 91,90 92,15 -1,16% 3,82% 4.304.300
26/08/2019 94,61 94,83 92,33 93,23 -0,41% 2,64% 1.476.100
23/08/2019 94,53 96,49 92,98 93,61 -1,54% 3,71% 1.800.400
22/08/2019 101,28 101,65 90,24 95,07 -6,33% 11,27% 5.768.400
21/08/2019 101,71 103,37 99,65 101,50 -0,56% 3,66% 2.136.800
20/08/2019 98,40 105,77 96,79 102,07 -15,16% 9,13% 10.309.800
19/08/2019 125,44 126,71 120,16 120,31 -3,71% 5,22% 1.544.600
16/08/2019 123,35 126,19 123,12 124,95 +2,44% 2,49% 1.223.600
15/08/2019 123,75 126,50 121,28 121,97 -1,31% 4,22% 973.600
14/08/2019 124,01 125,67 122,11 123,59 -2,03% 2,87% 1.372.400
13/08/2019 125,64 130,72 124,14 126,15 +1,62% 5,24% 1.341.400
12/08/2019 126,40 128,91 122,01 124,14 -1,56% 5,46% 1.713.100
09/08/2019 131,86 133,34 125,29 126,11 -5,17% 6,10% 2.135.000
08/08/2019 136,88 137,00 115,00 132,98 -6,52% 16,07% 6.001.700
07/08/2019 142,10 143,42 139,10 142,26 -0,87% 3,04% 1.001.200
06/08/2019 143,95 145,83 140,50 143,51 +0,57% 3,70% 1.188.600
05/08/2019 143,15 144,63 138,66 142,70 -2,35% 4,17% 1.086.700
02/08/2019 147,89 148,24 141,50 146,14 -1,27% 4,56% 1.070.600
01/08/2019 149,61 153,00 146,59 148,02 -0,56% 4,28% 949.600
31/07/2019 148,79 152,51 147,65 148,85 -0,54% 3,27% 981.100
30/07/2019 148,42 150,14 146,59 149,66 +1,04% 2,39% 623.200
29/07/2019 149,70 150,33 146,34 148,12 -0,84% 2,67% 498.200